Dr. Liz Kwo Joins BrainCheck Board of Directors

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck, the leading digital cognitive assessment and care platform, today announced that Liz Kwo, MD, MBA, MPH, has joined its Board of Directors.

Dr. Kwo is a nationally recognized physician executive, healthcare operator, and board leader with deep experience spanning clinical care, digital health, population health, payer and provider organizations, and public and private company governance. She is a Fulbright Scholar, an honor recognizing her early leadership and contributions to healthcare systems and public health innovation

Dr. Kwo holds a Bachelor of Arts in Human Biology from Stanford University, a Doctor of Medicine from Harvard Medical School, a Master of Business Administration from Harvard Business School, and a Master of Public Health from the Harvard T.H. Chan School of Public Health, with a focus on population health. She is board-certified in Preventive Medicine (Occupational and Environmental Medicine) following residency training focused on prevention, early disease detection, chronic disease management, and healthcare utilization.

She currently serves as Chief Commercial Officer at Everly Health, where she leads a $100M+ P&L, overseeing commercialization, clinical innovation, and the launch of first-to-market diagnostic products. Previously, she served as Chief Medical Officer at Everly Health, leading clinical programs, telehealth strategy, quality and FDA oversight, and provider network development

Earlier in her career, Dr. Kwo held senior leadership roles at Anthem (now Elevance Health), including Deputy Chief Clinical Officer and Staff Vice President of Clinical Data Analytics, where she modernized population health strategies across Commercial, Medicare, Medicaid, and employer populations, with a focus on digital care management, cost of care, Stars and HEDIS performance

Dr. Kwo has also founded, scaled, and exited healthcare technology companies, including serving as CEO and Co-Founder of InfiniteMD, a technology-enabled medical second-opinion platform acquired by ConsumerMedical (now part of Alight). She has held executive roles at Amwell, helping scale the nation’s first large-scale online medical group, and has experience in venture investing and medical device innovation

In addition to her operating experience, Dr. Kwo brings extensive board and governance expertise, serving on the boards of public and private healthcare companies, including Kestra Medical Technologies, Walmart de México y Centroamérica (Audit Committee), Asensus Surgical (Compensation Committee), Mass General Brigham Innovation, and multiple venture-backed healthcare and medical technology companies. She has chaired governance and nominating committees and completed advanced executive education in corporate governance, audit committees, compensation committees, ESG materiality, and cybersecurity leadership

“Dr. Kwo brings an extraordinary combination of clinical training, operating leadership, and board-level governance expertise,” said Chris Loughlin, CEO of BrainCheck. “Her experience scaling digital health platforms and operating across payer, provider, and technology environments will be invaluable as BrainCheck continues to grow.”

“I’m excited to join the BrainCheck Board at a pivotal moment for cognitive care,” said Dr. Kwo. “Early detection, objective assessment, and scalable care models are essential to addressing the growing burden of cognitive impairment, and BrainCheck is well-positioned to help lead that transformation.”

As a member of the Board of Directors, Dr. Kwo will support BrainCheck’s strategic direction, partnerships, and long-term vision to modernize cognitive assessment and care across clinical and research settings.

For more information, visit www.braincheck.com.

About BrainCheck

BrainCheck is a clinically validated digital platform for cognitive assessment and care, anchored by BrainCheck Assess™—its flagship, FDA Class II–cleared digital cognitive assessment that delivers standardized, repeatable cognitive data across clinical and research settings. BrainCheck is used by more than 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic, and 46 research hospitals, including The University of Texas at Austin and Stanford University. Clinicians use BrainCheck’s validated screeners and care planning tools to build tailored protocols, with more than 640,000 cognitive tests and 14,000 Care Plans completed to date. BrainCheck is not intended for use as a stand-alone diagnostic tool.